Effectiveness study of gemcitabine, oxaliplatin, and capecitabine as first-line treatment for nonresectable biliary tract cancer

被引：0
|
作者：
Jensen, Lars Henrik
Mellergaard, Anne Haahr
Hoegdall, Dan
Larsen, Ole
机构：
[1] Vejle Hosp, Danish Colorectal Canc Grp South, Vejle, Denmark
[2] Univ Southern Denmark, Vejle, Denmark
[3] Univ Copenhagen, Herlev Hosp, Dept Oncol, DK-2730 Herlev, Denmark
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 03期
关键词：
D O I：
10.1200/jco.2014.32.3_suppl.334
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
334
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Three-weekly oxaliplatin combined with gemcitabine and capecitabine in the first-line treatment of patients with advanced biliary tract cancer
    Petrioli, Roberto
    Roviello, Giandomenico
    Fiaschi, Anna I.
    Laera, Letizia
    Roviello, Franco
    Marrelli, Daniele
    Francini, Edoardo
    ANTI-CANCER DRUGS, 2015, 26 (06) : 682 - 686
  • [2] Cost-Effectiveness Analysis of Capecitabine Plus Oxaliplatin Versus Gemcitabine Plus Oxaliplatin as First-Line Therapy for Advanced Biliary Tract Cancers
    Chen, Ruijia
    Zhang, Yalan
    Lin, Kongying
    Huang, Defu
    You, MaoJin
    Lai, Yanjin
    Wang, Jinye
    Hu, Yingying
    Li, Na
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [3] Phase II study of gemcitabine and oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer
    Kim, H.
    Lee, S.
    Bae, S.
    Kim, C.
    Lee, N.
    Lee, K.
    Park, S.
    Won, J.
    Hong, D.
    Park, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] A phase II study of gemcitabine in combination with oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer
    Hyun Jung Kim
    Nam Su Lee
    Sang-Cheol Lee
    Sang Byung Bae
    Chan Kyu Kim
    Young Gook Cheon
    Young Seok Kim
    Jong Ho Moon
    Young Deok Cho
    Sang Heum Park
    Kyu Taek Lee
    Sung Kyu Park
    Jong-Ho Won
    Hee Sook Park
    Dae Sik Hong
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 371 - 377
  • [5] A phase II study of gemcitabine in combination with oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer
    Kim, Hyun Jung
    Lee, Nam Su
    Lee, Sang-Cheol
    Bae, Sang Byung
    Kim, Chan Kyu
    Cheon, Young Gook
    Kim, Young Seok
    Moon, Jong Ho
    Cho, Young Deok
    Park, Sang Heum
    Lee, Kyu Taek
    Park, Sung Kyu
    Won, Jong-Ho
    Park, Hee Sook
    Hong, Dae Sik
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (02) : 371 - 377
  • [6] Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma
    Cho, JY
    Paik, YH
    Chang, YS
    Lee, SJ
    Lee, DK
    Song, SY
    Chung, JB
    Park, MS
    Yu, JS
    Yoon, DS
    CANCER, 2005, 104 (12) : 2753 - 2758
  • [7] Gemcitabine, capecitabine and oxaliplatin in advanced biliary tract carcinoma
    Larsen, Finn Ole
    Mellergaard, Anne Haahr
    Hoegdall, Dan Taksony Solyom
    Jensen, Lars Henrik
    ACTA ONCOLOGICA, 2014, 53 (10) : 1448 - 1450
  • [8] Chemotherapy with gemcitabine as first-line treatment for advanced biliary tract carcinoma
    Giacobino, A.
    Satolli, M. A.
    Dongiovanni, D.
    Rahimi, F.
    Milanesi, E.
    Zanini, M.
    Scigliano, M. C.
    Monge, T.
    Ceccarelli, M.
    Novarino, A.
    Ciorba, A.
    Manazza, A.
    Bertetto, O.
    Ciuffreda, L.
    ANNALS OF ONCOLOGY, 2007, 18 : 16 - 16
  • [9] Phase II study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancer
    Zeuli, M
    Nardoni, C
    Pino, MS
    Gamucci, T
    Gabriele, A
    Ferraresi, V
    Giannarelli, D
    Cognetti, F
    ANNALS OF ONCOLOGY, 2003, 14 (09) : 1378 - 1382
  • [10] GEMCITABINE AND CAPECITABINE (GEMCAP) AS FIRST-LINE CHEMOTHERAPY IN ADVANCED BILIARY TRACT ADENOCARCINOMAS: RESULTS OF A PHASE II STUDY
    Rozzi, A.
    Corona, M.
    Nardoni, C.
    Restuccia, M.
    Falbo, T.
    Lanzetta, G.
    ANNALS OF ONCOLOGY, 2010, 21 : 102 - 102
12345